En 语言
Search
Submit
Cancel

Company profile

Zhejiang Hisun Biomaterials Co., Ltd. (hereinafter referred to as the "HISUN"), established in August 2004, is a high-tech enterprise integrating R&D, production and sales of PLA. Through independent R&D, HISUN has broken through the "bottleneck" technology of industrial production of key raw material Lactide, and realized localization of PLA resin. It is the first listed company specializing in PLA business in China(Stock name: Hisun Biomaterials, stock code: 688203).

 

Since its establishment, HISUN has been adhering to the values of "developing plant resources and creating a harmonious society", and guided by customers and the market, through continuous R&D and innovation, constantly promote the deep integration of PLA industry and downstream material application industry. HISUN is the first drafter of PLA national standard, and has undertaken the national "863" project, has won the titles of National High-tech Industrialization Demonstration Project, National "Little Giant", and Zhejiang High-tech Enterprise Research and Development Center. With the promotion and implementation of plastic ban at home and abroad, as well as the steady progress of carbon emission reduction, the green material industry represented by PLA will usher in better development opportunities. HISUN will continue to cultivate new quality productive forces, achieve high-quality and sustainable development and create a better future.

 

Subsidiary

Zhejiang Honor Biomaterials Co., Ltd.

HONOR Biomaterials, whose annual capacity is 50kt, has been fully put into operation.

旗下子公司

Development path

  • 2024

    2023
    The 2nd Phase of the Project(15kt/a) was put into production.
  • 2004

    2004
    Zhejiang Hisun Biomaterials Co., Ltd. was established.
  • 2004

    2004
    30 tons/year PLA trial facility was built and put into operation, and small-scale production process chain of PLA has been preliminarily mastered.
  • 2008

    2008
    5,000 tons/year PLA production line was completed and achieved stable production, which laid foundation for the 10,000-ton polylactic acid production line.
  • 2015

    2015
    Build a polylactic acid production line with an annual output of 10,000 tons and a processing and modification production line for related products.
  • 2020

    2020
    The 1st Phase of the Project(15kt/a) was put into production in December.
  • 2024

    2022
    Hisun was listed in SSE STAR MARKET(stock code: 688203) .
  • 2024

    2023
    The 2nd Phase of the Project(15kt/a) was put into production.
Pre
1

Company honor

Search
Search
Copyright ©Zhejiang Hisun Biomaterials Co., Ltd. 浙ICP备14023017号-1 Powered by 300.cn

返回顶部